Table 1. Development and implementation of policies for co-trimoxazole prophylaxis and isoniazid preventive therapy in World Health Organization regions, 2007.

Region	Countries receiving survey		Countries responding to survey			Countries with CTXp policy			Countries with nationwide implementation of CXTp policya			Countries with IPT policy			Countries with nationwide implementation of IPT policya		Respondent countries
	No.		No.	%		No.	%		No.	%		No.	%		No.	%
African Region	31		17	55		16	94		11	69		8	47		1	13	Angola, Botswana, Central African Republic, Côte d'Ivoire, Ethiopia, Ghana, Lesotho, Malawi, Mozambique, Nigeria, Rwanda, South Africa, Swaziland, Uganda, United Republic of Tanzania, Zambia, Zimbabwe
Region of the Americas	10		6	60		6	100		4	67		5	83		2	40	Bahamas, Brazil, Colombia, Guyana, Haiti, Trinidad and Tobago
Eastern Mediterranean Region	5		3	60		3	100		2	67		1	33		1	100	Iran, Somalia, Sudan
European Region	11		7	64		6	86		3	50		5	71		2	40	Armenia, Kyrgyzstan, Republic of Moldova, Russian Federation, Tajikistan, The former Yugoslav Republic of Macedonia, Ukraine
South-East Asia Region	5		4	80		4	100		2	50		2	50		0	0	India, Indonesia, Nepal, Thailand
Western Pacific Region	7		4	57		3	75		3	100		0	0		0	0	Cambodia, China, Philippines, Viet Nam
Total	69		41	59		38	93		25	66		21	51		6	28	All countries

CTXp, co-trimoxazole prophylaxis; ITP, isoniazid preventive therapy.

^a Countries providing co-trimoxazole prophylaxis and isoniazid preventive therapy to people living with HIV in all the regions and districts in the country were considered to have achieved nationwide implementation.